Every Form 4 that Microvast Holdings, Inc. Warrants (MVSTW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MVSTW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MVSTW filings page.
Microvast Holdings, Inc. director and officer Tushe Isida reported two updates to her common stock holdings. On March 10, 2026, she acquired 15,503 shares at no cost, earned from performance stock units after the compensation committee certified performance results.
On June 9, 2026, she sold 6,403 shares of common stock at $1.24 per share in an open‑market transaction described as a “sell to cover” sale to satisfy tax withholding obligations related to restricted stock unit settlement under the 2021 Equity Incentive Plan. After these transactions, she directly holds 184,100 shares of Microvast common stock.
Microvast Holdings, Inc. Chief Technology Officer Wenjuan Mattis reported a small share sale tied to equity compensation. On this Form 4, Mattis sold 4,705 shares of common stock at $1.10 per share in a “sell to cover” transaction. According to the footnote, the sale was made to cover tax withholding obligations arising from the settlement of restricted stock units granted under the Microvast Holdings, Inc. 2021 Equity Incentive Plan. After this tax-related disposition, Mattis directly holds 927,973 shares of Microvast common stock.
Microvast Holdings, Inc. Chief Executive Officer Wu Yang reported an insider transaction involving the company’s common stock. On June 9, 2026, he sold 46,313 shares at $1.24 per share in a “sell to cover” trade to satisfy tax withholding tied to the settlement of restricted stock units under the Microvast Holdings, Inc. 2021 Equity Incentive Plan. After this disposition, he directly holds 134,065,439 shares of common stock and indirectly holds 1,000,000 shares through his son, who shares the reporting person’s household. The transaction is compensation- and tax-related rather than a discretionary open-market sale.
Microvast Holdings, Inc. director and CEO Wu Yang converted a $25,000,000 convertible loan into 50,000,000 shares of common stock at an effective conversion price of $0.50 per share. Following the conversion, he directly holds 134,111,752 shares of common stock and indirectly holds 1,000,000 shares through his son’s household. Yang also continues to hold a warrant exercisable for 5,500,000 shares of common stock at an exercise price of $2.00 per share, expiring on May 28, 2029. The filing reflects a significant shift from debt exposure to equity exposure rather than an open-market purchase or sale.
Microvast Holdings, Inc. Chief Technology Officer Mattis Wenjuan reported an open-market sale of 48,346 shares of common stock at $1.32 per share. According to the footnote, these shares were sold solely to cover tax withholding obligations tied to the settlement of restricted and performance stock units under the company’s 2021 Equity Incentive Plan. After this transaction, Wenjuan directly holds 932,678 shares of Microvast common stock.
Microvast Holdings, Inc. director Ying Wei received an equity award of 20,000 restricted stock units of common stock as part of the company’s non-employee director compensation policy. This is a grant, not an open-market purchase or sale, and carries no cash exercise price.
Each restricted stock unit represents a contingent right to receive one share of Microvast common stock. The units vest on December 31, 2026, subject to Ying Wei’s continued service on the board through that date. Following this award, Ying Wei directly holds a total of 388,789 shares of Microvast common stock.
Pan Yixin reported acquisition or exercise transactions in this Form 4 filing.
Microvast Holdings, Inc. director Pan Yixin received an equity award in the form of 20,000 shares of common stock on a grant basis. The award represents restricted stock units granted under the company’s non-employee director compensation policy at a price of $0.00 per share. Each restricted stock unit corresponds to one share of common stock and will vest on December 31, 2026, subject to continued board service through that date. Following this grant, Pan Yixin directly holds a total of 188,239 shares of Microvast common stock.
Wong Arthur Lap Tat reported acquisition or exercise transactions in this Form 4 filing.
Microvast Holdings director Arthur Lap Tat Wong received an equity award rather than buying shares on the market. He was granted 20,000 restricted stock units under the non-employee director compensation policy, each equal to one common share. These units vest on December 31, 2026, assuming he continues to serve through that date. After this grant, he holds 237,473 common shares directly.
Microvast Holdings, Inc. Chief Operating Officer Wu Shengxian reported multiple equity-based compensation awards. The latest Form 4 shows grants of common stock and cash-settled restricted and performance stock units tied to the value of Microvast common shares.
The filing also reports a prior grant of an employee stock option covering 1,000,000 shares of common stock at an exercise price of $1.2900 per share, vesting in three equal installments starting on November 8, 2025 and expiring on December 5, 2034. Following the most recent grant on March 13, 2026, Wu directly holds 233,799 shares of common stock.
Microvast Holdings, Inc. Chief Technology Officer Mattis Wenjuan acquired 112,500 shares of common stock on March 2, 2026 through a grant classified as a "grant, award, or other acquisition." These shares were earned from performance stock units that vested after achievement of performance conditions over the applicable period.
Following this equity award, Wenjuan directly owns 970,689 shares of Microvast common stock. The reported transaction carried a price per share of $0.0000, reflecting that it was compensation-based rather than an open-market purchase.
Ying Wei reported acquisition or exercise transactions in this Form 4 filing.
Microvast Holdings, Inc. director Ying Wei reported two equity awards of common stock in the form of restricted stock units granted under the company’s non-employee director compensation policy. These are compensation grants rather than open-market purchases or sales.
The first award covers 37,500 restricted stock units, each representing a right to receive one share of common stock, vesting on December 31, 2026, contingent on continued board service. The second award covers 30,357 restricted stock units, vesting in four equal installments on March 31, 2026, June 30, 2026, September 30, 2026, and December 31, 2026, also subject to continued service.
Wong Arthur Lap Tat reported acquisition or exercise transactions in this Form 4 filing.
Microvast Holdings director Arthur Lap Tat Wong received an equity grant in the form of restricted stock units. On January 1, 2026, he was awarded 37,500 restricted stock units of Microvast common stock at no cash cost to him, as part of the company’s non-employee director compensation policy.
Each unit represents the right to receive one share of common stock, but the award will only vest on December 31, 2026 if he continues serving as a director through that date. After this grant, he beneficially owns 217,473 shares of Microvast common stock directly.
Microvast Holdings director Pan Yixin received an equity grant of 37,500 restricted stock units on January 1, 2026. The award was made under the company’s non-employee director compensation policy and carries no cash exercise price.
Each restricted stock unit represents a right to receive one share of Microvast common stock, vesting on December 31, 2026, contingent on continued board service through that date. Following this grant, Pan is reported as beneficially owning 168,239 shares of common stock in total, held directly.
Microvast Holdings Chief Financial Officer Rodney Worthen reported a mix of stock grants and an automatic tax-related sale of company shares. On August 10, 2025 he received 15,000 restricted stock units (RSUs) that vest in three equal installments on August 10, 2026, 2027 and 2028. On November 25, 2025 he sold 2,671 common shares at $3.48 each in an automatic “sell to cover” transaction to satisfy tax withholding tied to RSU settlement, described as not a discretionary trade. On January 9, 2026 he received an additional 85,714 RSUs, vesting in equal installments on January 9, 2027, 2028 and 2029. Following these transactions, he held 117,422 shares of Microvast common stock directly.